Vision Training for Age-Related Macular Degeneration
(FLAP Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that low vision rehabilitation, which includes training with magnifying aids, can improve reading speed, emotional well-being, and quality of life for people with age-related macular degeneration.
12345The studies reviewed do not specifically address the safety of vision training for age-related macular degeneration, but they do not report any safety concerns or adverse effects related to the training methods used.
26789The Vision Training treatment for Age-Related Macular Degeneration is unique because it focuses on improving visual skills through exercises like eye-movement training and biofeedback, rather than relying solely on magnification aids or medications. This approach aims to enhance reading speed, visual acuity, and quality of life by training the brain to use healthier parts of the retina more effectively.
28101112Eligibility Criteria
This trial is for adults aged 18-89 with severe vision impairment (20/100 or worse) due to Macular Degeneration, confirmed by an ophthalmologist. Participants must have had this condition for at least two years and live within 50 miles of the study site. Those with certain body measurements, metal implants, claustrophobia, hearing impairments, significant head injuries, mental health conditions like hallucinations/delusions, or specific tattoos near the head cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo perceptual learning training focusing on visual sensitivity, spatial integration, and attention and eye-movements.
Follow-up
Participants are monitored for changes in visual processing and brain plasticity after training completion.